|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/605 | (2006.01) |
| C07K 14/605 | (2013.01) | ||
| A61K 38/26 | (2006.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 3/10 | (2018.01) | ||
| A61K 47/542 | (2017.08) |
| (11) | Patento numeris | 3551651 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17832211.1 |
| Europos patento paraiškos padavimo data | 2017-12-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2024-03-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/082290 |
| Data | 2017-12-11 |
| (87) | Numeris | WO 2018/104561 |
| Data | 2018-06-14 |
| (30) | Numeris | Data | Šalis |
| PA201600757 | 2016-12-09 | DK |
| (72) |
DUE LARSEN, Bjarne , DK
GRIFFIN, Jonathan , SE
GIEHM, Lise , DK
EDWARDS, Alistair Vincent Gordon , DK
|
| (73) |
Zealand Pharma A/S ,
Sydmarken 11, 2860 Søborg,
DK
|
| (54) | ACYLATED GLP-1/GLP-2 DUAL AGONISTS |
| ACYLATED GLP-1/GLP-2 DUAL AGONISTS |